Profil
Paul Rounding is Chairman and Chief Executive Officer of Artemis Pharmaceuticals GmbH.
He joined ARTEMIS in January 2000.
Previously, he held various positions in the pharmaceutical business group at Bayer AG.
Dr. Rounding received a BS degree in Pharmacology from the University of Bath and a PhD in Pharmacology from London University.
Tidigare kända positioner av Paul Rounding
| Företag | Position | Slut |
|---|---|---|
Taconic Biosciences GmbH
Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Researches genetics and functional genomics | Företagsledare/Principal | 2012-09-01 |
| BAYER AG | Företagsledare/Principal | - |
Paul Roundings utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 4 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taconic Biosciences GmbH
Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Researches genetics and functional genomics | Commercial Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















